Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of C Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Ip more than expected).
This network shows the impact of papers produced by C Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Ip. The network helps show where C Ip may publish in the future.
Co-authorship network of co-authors of C Ip
This figure shows the co-authorship network connecting the top 25 collaborators of C Ip.
A scholar is included among the top collaborators of C Ip based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Ip. C Ip is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ip, C, Donald J. Lisk, & Howard E. Ganther. (2001). Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.. PubMed. 20(6B). 4179–82.22 indexed citations
3.
Ip, C, et al.. (2000). Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland.. PubMed. 9(7). 689–96.86 indexed citations
4.
Ip, C, D. J. Lisk, & Howard E. Ganther. (1999). Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents.. PubMed. 18(6A). 4019–25.34 indexed citations
5.
Ip, C, et al.. (1998). Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile.. PubMed. 17(5A). 3195–9.28 indexed citations
6.
Ip, C, et al.. (1998). Cytostasis and cancer chemoprevention: investigating the action of triphenylselenonium chloride in in vivo models of mammary carcinogenesis.. PubMed. 18(1A). 9–12.11 indexed citations
7.
Zhu, Zhiwei, et al.. (1997). Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk.. PubMed. 57(22). 5067–72.101 indexed citations
Ip, C. (1990). Quantitative assessment of fat and calorie as risk factors in mammary carcinogenesis in an experimental model.. PubMed. 346. 107–17.29 indexed citations
12.
Ip, C & Howard E. Ganther. (1990). Activity of methylated forms of selenium in cancer prevention.. PubMed. 50(4). 1206–11.180 indexed citations
Ip, C, et al.. (1986). Serum and tumor sialyltransferase activities in women with breast cancer.. PubMed. 204. 31–43.3 indexed citations
15.
Ip, C. (1986). Selenium and experimental cancer.. PubMed. 18(1). 22–9.28 indexed citations
16.
Ip, C, et al.. (1986). Relevance of trans fatty acids and fish oil in animal tumorigenesis studies.. PubMed. 222. 283–94.13 indexed citations
17.
Ip, C, et al.. (1985). Effects of selenium on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis and DNA adduct formation.. PubMed. 45(1). 61–5.37 indexed citations
18.
Ip, C, Brown Ml, & Smith Hc. (1981). Radionuclide measurement of left ventricular volume.. PubMed. 56(12). 733–9.35 indexed citations
19.
Ip, C, et al.. (1980). Failure of interventions to maintain mitochondrial function in ischemic myocardium.. PubMed. 55(10). 637–44.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.